Distinguished in Esophageal Cancer

Dr. Heath D. Skinner

Radiation Oncology
University Of Pittsburgh Cancer Institute Cancer Services
100 Fairfield Dr, 
Seneca, PA 
Clinical Trials:Currently Recruiting for 2 Trials
Distinguished in Esophageal Cancer
University Of Pittsburgh Cancer Institute Cancer Services
100 Fairfield Dr, 
Seneca, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Heath Skinner is a Radiation Oncologist in Seneca, Pennsylvania. Dr. Skinner is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Cancer, Anaplastic Thyroid Cancer, Lung Cancer, and Gastrostomy.

His clinical research consists of co-authoring 162 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 29 articles in the study of Esophageal Cancer.

Specialties
Radiation Oncology
Licenses
Radiology in PA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

UNIVERSITY OF PITTSBURGH CANCER INSTITUTE CANCER SERVICES
100 Fairfield Dr, Seneca, PA 16346
Call: 814-676-7900

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Enrollment Status: Recruiting
Publish Date: May 25, 2025
Intervention Type: Procedure, Radiation
Study Phase: Phase 3
A Randomized, Phase II Study of Definitive Radiotherapy With Concurrent Cisplatin vs. Docetaxel-cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma: an ERCC1 Biomarker Enrichment and Interaction Design
A Randomized, Phase II Study of Definitive Radiotherapy With Concurrent Cisplatin vs. Docetaxel-cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma: an ERCC1 Biomarker Enrichment and Interaction Design
Enrollment Status: Recruiting
Publish Date: March 26, 2025
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Docetaxel, Cetuximab
Study Phase: Phase 2
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2025
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
An Open-label, Phase 1, Dose-escalation Study to Evaluate the Safety and Preliminary Antitumor Activity of TAK-676 With Pembrolizumab Following Radiation Therapy in the Treatment of Non-small-cell Lung Cancer, Triple-negative Breast Cancer, or Squamous-cell Carcinoma of the Head and Neck That Has Progressed on Checkpoint Inhibitors
An Open-label, Phase 1, Dose-escalation Study to Evaluate the Safety and Preliminary Antitumor Activity of TAK-676 With Pembrolizumab Following Radiation Therapy in the Treatment of Non-small-cell Lung Cancer, Triple-negative Breast Cancer, or Squamous-cell Carcinoma of the Head and Neck That Has Progressed on Checkpoint Inhibitors
Enrollment Status: Completed
Publish Date: September 04, 2025
Intervention Type: Drug, Radiation
Study Drugs: Pembrolizumab, TAK-676
Study Phase: Phase 1
Tumor Mutation Status Will Predict Metabolic Response to Metformin in Non Small Cell Lung Cancer (NSCLC)
Tumor Mutation Status Will Predict Metabolic Response to Metformin in Non Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: January 06, 2020
Intervention Type: Other, Radiation, Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

161 Total Publications

Interim Analysis of Dose-Escalated Preoperative Breast Irradiation: A Phase Ib study.
Interim Analysis of Dose-Escalated Preoperative Breast Irradiation: A Phase Ib study.
Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025
View All 161 Publications
Similar Doctors
Patrizia Guerrieri
Experienced in Esophageal Cancer
Dr. Patrizia Guerrieri
Radiation Oncology
Experienced in Esophageal Cancer
Dr. Patrizia Guerrieri
Radiation Oncology

Mercy Health — Boardman Medical Oncology

8401 Market Street, 
Boardman, OH 
 (56.0 miles away)
330-729-7530
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients

Patrizia Guerrieri is a Radiation Oncologist in Boardman, Ohio. Dr. Guerrieri is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. Her top areas of expertise are Breast Cancer, Endometrial Cancer, Endometrial Stromal Sarcoma, and Cervical Cancer. Dr. Guerrieri is currently accepting new patients.

VIEW MORE ESOPHAGEAL CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Skinner's expertise for a condition
ConditionClose
  • Elite
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
    Dr. Skinner is
    Elite
    . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
    See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
  • Distinguished
  • Esophageal Cancer
    Dr. Skinner is
    Distinguished
    . Learn about Esophageal Cancer.
    See more Esophageal Cancer experts
  • Advanced
  • Anaplastic Thyroid Cancer
    Dr. Skinner is
    Advanced
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Human Papillomavirus Infection
    Dr. Skinner is
    Advanced
    . Learn about Human Papillomavirus Infection.
    See more Human Papillomavirus Infection experts
  • Lung Cancer
    Dr. Skinner is
    Advanced
    . Learn about Lung Cancer.
    See more Lung Cancer experts
  • Experienced
  • Acinic Cell Carcinoma of Salivary Glands
    Dr. Skinner is
    Experienced
    . Learn about Acinic Cell Carcinoma of Salivary Glands.
    See more Acinic Cell Carcinoma of Salivary Glands experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Skinner is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • EGFR Positive Lung Cancer
    Dr. Skinner is
    Experienced
    . Learn about EGFR Positive Lung Cancer.
    See more EGFR Positive Lung Cancer experts
  • Gastroesophageal Junction Cancer
    Dr. Skinner is
    Experienced
    . Learn about Gastroesophageal Junction Cancer.
    See more Gastroesophageal Junction Cancer experts
  • Gastrostomy
    Dr. Skinner is
    Experienced
    . Learn about Gastrostomy.
    See more Gastrostomy experts
  • Large-Cell Lung Carcinoma
    Dr. Skinner is
    Experienced
    . Learn about Large-Cell Lung Carcinoma.
    See more Large-Cell Lung Carcinoma experts
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.